Uniphar (LON:UPR) Hits New 52-Week Low – Time to Sell?

Uniphar plc (LON:UPR)’s stock price hit a new 52-week low on Tuesday . The company traded as low as GBX 166 ($2.09) and last traded at GBX 166.65 ($2.10), with a volume of 19668 shares changing hands. The stock had previously closed at GBX 171.50 ($2.16).

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 310 ($3.90) target price on shares of Uniphar in a research note on Wednesday, September 4th.

Uniphar Stock Performance

The company has a market capitalization of £475.05 million, a price-to-earnings ratio of 1,211.71 and a beta of 0.75. The company has a debt-to-equity ratio of 119.43, a current ratio of 0.90 and a quick ratio of 0.60. The stock has a 50 day moving average price of GBX 203.57 and a two-hundred day moving average price of GBX 212.98.

Uniphar Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, October 4th. Investors of record on Thursday, September 12th were issued a €0.01 ($0.01) dividend. This represents a yield of 0.25%. The ex-dividend date of this dividend was Thursday, September 12th. Uniphar’s dividend payout ratio is 1,428.57%.

Uniphar Company Profile

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.